Home > Annual Financials > SUN PHARMA ADVANCED RESEARCH COMPANY

SUN PHARMA ADVANCED RESEARCH COMPANY Financial Statement Analysis
[BOM: 532872|NSE : SPARC]

The Revenues of SUN PHARMA ADVANCED RESEARCH COMPANY have increased by 73.98% YoY .
The Earnings Per Share (EPS) of SUN PHARMA ADVANCED RESEARCH COMPANY has decreased by Negative YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Annual Financial Results
[BOM: 532872|NSE : SPARC]

StandaloneMar2023
Mar2022
Mar2021
Mar2020
Mar2019
Revenues ₹239 Cr₹137 Cr₹253 Cr₹77 Cr₹183 Cr
Expenses ₹453 Cr₹324 Cr₹388 Cr₹387 Cr₹334 Cr
Operating Profit (Excl OI) ₹-214 Cr₹-187 Cr₹-135 Cr₹-310 Cr₹-151 Cr
Other Income ₹11 Cr₹6.85 Cr₹5.41 Cr₹9.76 Cr₹14 Cr
Interest ₹7.64 Cr₹13 Cr₹11 Cr₹2.68 Cr₹0.09 Cr
Depreciation ₹12 Cr₹10 Cr₹11 Cr₹9.48 Cr₹7.55 Cr
Profit Before Tax ₹-223 Cr₹-203 Cr₹-151 Cr₹-312 Cr₹-145 Cr
Profit After Tax ₹-223 Cr₹-203 Cr₹-151 Cr₹-312 Cr₹-145 Cr
Consolidated Net Profit ₹-223 Cr₹-203 Cr₹-151 Cr₹-312 Cr₹-145 Cr
Earnings Per Share (Rs)₹-6.86₹-7.48₹-5.77₹-11.92₹-5.55
PAT Margin (%)-93.22-148.19-59.75-406.70-79.53
ROE(%)-143.720.000.00-225.08-74.72
ROCE(%)-69.44-225.57-254.10-178.95-59.95
Total Debt/Equity(x)0.00-0.37-1.37-3.590.01

Key Financials

Market Cap : ₹ 11,396.4 Cr
Revenue (TTM) : ₹ 106.7 Cr
Net Profit(TTM) : ₹ -363.4 Cr
EPS (TTM) : ₹ -11.2
P/E (TTM) : -

Industry Peers & Returns1W1M1Y
SUN PHARMA ADVANCED RESEARCH COMPANY 3.3% 2.8% 129.7%
SYNGENE INTERNATIONAL 4.7% -5.2% 20.9%
LATENT VIEW ANALYTICS 3.3% -11.9% 31.4%
JUST DIAL -0% -15.9% 32.9%
DREAMFOLKS SERVICES 0.6% -3.2% 11.7%
EKI ENERGY SERVICES -5.8% -22.3% -46.6%
AGS TRANSACT TECHNOLOGIES -2.3% -26.1% 30.8%
JAYKAY ENTERPRISES 0.3% -20.1% 147.5%
QUINT DIGITAL 0.7% -19.3% -3.2%


SUN PHARMA ADVANCED RESEARCH COMPANY Revenues
[BOM: 532872|NSE : SPARC]

Y-o-Y

73.98 %

5 Yr CAGR

6.90 %

Years Revenues % Change
Mar2023 ₹239 Cr
73.98
Mar2022 ₹137 Cr
-45.74
Mar2021 ₹253 Cr
229.31
Mar2020 ₹77 Cr
-58.00
Mar2019 ₹183 Cr -


SUN PHARMA ADVANCED RESEARCH COMPANY Operating Profit
[BOM: 532872|NSE : SPARC]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years Operating Profit % Change
Mar2023 ₹-214 Cr
Negative
Mar2022 ₹-187 Cr
Negative
Mar2021 ₹-135 Cr
Negative
Mar2020 ₹-310 Cr
Negative
Mar2019 ₹-151 Cr -

Operating Margins
Y-o-Y

Negative

5 Yr CAGR

Negative

Years Operating Margin% % Change
Mar2023 -89.65%
Negative
Mar2022 -136.07%
Negative
Mar2021 -53.36%
Negative
Mar2020 -403.59%
Negative
Mar2019 -82.73% -

SUN PHARMA ADVANCED RESEARCH COMPANY Profit After Tax
[BOM: 532872|NSE : SPARC]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years Profit After Tax % Change
Mar2023 ₹-223 Cr
Negative
Mar2022 ₹-203 Cr
Negative
Mar2021 ₹-151 Cr
Negative
Mar2020 ₹-312 Cr
Negative
Mar2019 ₹-145 Cr -

PAT Margins
Y-o-Y

Negative

5 Yr CAGR

Negative

Years PAT Margin(%) % Change
Mar2023 -93.22 %
Negative
Mar2022 -148.19 %
Negative
Mar2021 -59.75 %
Negative
Mar2020 -406.7 %
Negative
Mar2019 -79.53 % -

SUN PHARMA ADVANCED RESEARCH COMPANY Earnings Per Share (EPS)
[BOM: 532872|NSE : SPARC]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years EPS % Change
Mar2023 ₹-6.86
Negative
Mar2022 ₹-7.48
Negative
Mar2021 ₹-5.77
Negative
Mar2020 ₹-12
Negative
Mar2019 ₹-5.55 -

SUN PHARMA ADVANCED RESEARCH COMPANY Return on Capital Employed (ROCE)
[BOM: 532872|NSE : SPARC]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years ROCE % Change
Mar2023 -69.44%
Negative
Mar2022 -225.57%
Negative
Mar2021 -254.1%
Negative
Mar2020 -178.95%
Negative
Mar2019 -59.95% -

SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex

Current Share Price : ₹351.2
Current MarketCap: ₹ 11,396.4 Cr
Updated EOD on :Apr 18,2024

Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY

3.3%

2.8%

129.7%

SENSEX

-2.9%

-0.4%

20%

SUN PHARMA ADVANCED RESEARCH COMPANY related INDICES

BSE Indices1W1M1Y
S&P BSE 250 SMALLCAP -0.9% 12.1% 61.4%
S&P BSE SMALL CAP -1.1% 11.8% 62%
S&P BSE 400 MIDSMALLCAP -1.2% 8.6% 57.2%
S&P BSE MIDSMALLCAP -1.2% 9.4% 62.3%
S&P BSE ALLCAP -2.2% 3.9% 37%
NSE Indices1W1M1Y
NIFTY SMALLCAP250 -0.7% 12.7% 67.3%
NIFTY MID SMALL400 -1.2% 9.2% 59.9%
NIFTY500 MULTICAP 50:25:25 -1.8% 5.7% 44.8%
NIFTY 500 -2.2% 3.5% 36%

You may also like the below Video Courses


FAQ about SUN PHARMA ADVANCED RESEARCH COMPANY Financials


How the annual revenues of SUN PHARMA ADVANCED RESEARCH COMPANY have changed ?

The Revenues of SUN PHARMA ADVANCED RESEARCH COMPANY have increased by 73.98% YoY .

How the Earnings per Share (EPS) of SUN PHARMA ADVANCED RESEARCH COMPANY have changed?

The Earnings Per Share (EPS) of SUN PHARMA ADVANCED RESEARCH COMPANY has decreased by Negative YoY .